Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

Condition(s) studied

Investigational drug(s) / intervention(s)

No intervention will be given to patients.: Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.

Study summary

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Eligibility

Primary outcome measure(s)

• Confirmation of diagnosis by pathologist — Up to 3 years
  Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.

Trial sites (1)

More Renmin Hospital of Wuhan University trials in China

Other trials for the same condition